Ozempic, Wegovy, other GLP-1RA drugs not linked to increased pancreatic cancer risk, study finds
Posted:
New research has concluded that drugs from the glucagon-like peptide-1 receptor agonists (GLP-1RA) class do not increase the risk of pancreatic cancer.
As general-purpose AI like ChatGPT and Gemini make its way into people's everyday lives today, domain-specific ones like AI in cancer are also advancing, with only funding and critical infrastructure standing in the way of clinical use, according to one…
Infrastructure is easy to overlook and underinvest in. Roads, bridges, and electrical grids fade into the background, until a failure makes them impossible to ignore.
The same is becoming true for AI in healthcare. Over the past several years, health…
Attendees
Sponsors and Exhibitors
Contact us